Back to Directory
Last Updated: 05/06/2026

Revivocell

Liverpool
Founded 2015
Organ-on-a-chip platforms for pre-clinical drug toxicology research

Revivocell is a biotechnology company developing modular organ-on-a-chip and 3D cell culture platforms for pre-clinical drug discovery and toxicology research.

Its platforms enable researchers to build multi-cell-type organotypic models that replicate in-vivo organ conditions, including validated human liver models for drug-induced liver injury prediction.

Products are designed in standard laboratory plate formats for compatibility with routine workflows, and customised contract research services are also available.

Company Notes